LEWISTOWN - Lewistown Hospital confirmed on Tuesday that the pharmacy is clean of any contaminated product related to the fungal meningitis outbreak and that the hospital has never worked with the New England Compounding Center.
"Lewistown Hospital has not contracted with anyone for the compounding of sterile methylprednisolone acetate preservative free injection, the implicated agent responsible for the outbreak," said Kay Hamilton, president and CEO of Lewistown Hospital. "We take our commitment to patient safety very seriously and have procedures in place to assure the highest quality of care possible."
Lewistown Hospital goes through an extensive review of any prospective pharmaceutical product supplier and all current contracted suppliers for Lewistown Hospital are registered with the FDA, meet or exceed USP Chapter 797 standards and meet cGMP requirements.
In addition, any product selected for use on a patient is thoroughly examined for any potential problems and defects prior to administration.
"We take every measure to assure that patients are receiving a safe drug," noted Richard Stomackin, director of Pharmacy Services at the hospital.